Navigation Links
China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009
Date:9/9/2009

HARBIN, China, Sept. 9 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, will present at the Rodman and Renshaw Annual Global Investment Conference to be held on September 9-11, 2009 in New York. China Kangtai Cactus Biotech will present as part of the Asia Track program on September 11, 2009 at 1:10 p.m. ET in the Kennedy I Salon on the 4th floor of the New York Palace Hotel.

A live webcast and slides of the presentation will be available at http://www.wsw.com/webcast/rrshq15/ckgt.ob . The webcast will be available for approximately three months. The PowerPoint presentation will be available at: http://www.hawkassociates.com .

CEO Jinjiang Wang will be available to meet in scheduled sessions with institutional investors at the conference on September 9-11 or in New York from September 14-15 and in Southern California from September 17-18. Institutional investors seeking to arrange a one on one meeting or teleconference with management outside of the conference while management is in the U.S. can contact Susan Zhou, 305-451-1888 or cactus@hawkassociates.com.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

An online investor relations kit and investment profile on China Kangtai Cactus Biotech Inc. is available at http://www.hawkassociates.com/profile/ckgt.cfm . To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/ .

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements.

    For more information, please contact:

    Investor Contact:
     Hawk Associates
     Susan Zhou
     Tel:   +1-305-451-1888
     Email: cactus@hawkassociates.com

'/>"/>
SOURCE China Kangtai Cactus Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Sky One Medical, Inc. Exports Pain Relief Patch to Canada
2. China Sky One Medical, Inc. Submits Application to Perform Clinical Trials for Two New Eye Drugs to SFDA
3. China Pharma Holdings, Inc. Announces Participation in September Conferences
4. China Sky One Medical, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference and Conduct Non-Deal Roadshow in the U.S.
5. China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results
6. China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results
7. China Medicine Enhances Management Team with Appointments of New Chief Financial Officer and Finance Manager
8. China Sky One Medical, Inc. to Hold Annual Meeting of Shareholders on September 24, 2009
9. Linkwell Corporation Announces Launch of the Establishment of 100 Model Hospitals Across China
10. Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China
11. China Healthcare Corp. Provides Update on JV to Build its First Hospital in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: